Fig. 1: Responses to teclistamab in patients with relapsed/refractory multiple myeloma.

A Stacked bar graph illustrating the rate of PR, VGPR, CR, and sCR in 188 response-evaluable patients treated with teclistamab. Responses according to IMWG criteria. B Forest Plot of ORR in Subgroups.